# Prostate Artery Embolization for Symptomatic Benign Prostatic Hyperplasia

> **NCT02822924** · NA · COMPLETED · sponsor: **Chinese University of Hong Kong** · enrollment: 82 (actual)

## Conditions studied

- Benign Prostate Hyperplasia

## Interventions

- **PROCEDURE:** Prostate artery embolization (PAE)

## Key facts

- **NCT ID:** NCT02822924
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10-07
- **Primary completion:** 2021-03-10
- **Final completion:** 2021-03-10
- **Target enrollment:** 82 (ACTUAL)
- **Last updated:** 2022-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02822924

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02822924, "Prostate Artery Embolization for Symptomatic Benign Prostatic Hyperplasia". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02822924. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*